LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 86TH LEGISLATIVE REGULAR SESSION

March 19, 2019

TO:	Honorable Senfronia Thompson, Chair, House Committee on Public Health
FROM:	John McGeady, Assistant Director     Sarah Keyton, Assistant Director Legislative Budget Board
IN RE:	HB1710 by Ramos (Relating to discussing with a patient the risks of certain controlled substance prescriptions.), As Introduced

No significant fiscal implication to the State is anticipated.

The Texas Medical Board, Board of Dental Examiners, Texas Board of Nursing, Board of Pharmacy, and Board of Veterinary Medical Examiners indicate that the provisions of the bill relating to discussing with a patient the risks of certain controlled substance prescriptions could be absorbed using existing resources.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies:

503 Texas Medical Board, 504 Texas State Board of Dental Examiners, 507 Texas Board of Nursing, 515 Board of Pharmacy, 578 Board of Veterinary Medical Examiners

LBB Staff:

WP, AKi, SGr, ESt